Arcoma

Arcoma FCF Margin

The Free Cash Flow Margin of Arcoma (ARCOMA.ST) as of Oct 23, 2026 is 10.01 %. In the previous year, Free Cash Flow Margin was 7.69 % — a change of 30.14% (higher).

FCF Margin

10.01 %

YoY

30.14%

Last updated:

Free Cash Flow Margin of Arcoma is 2025 10.01 % . Free Cash Flow Margin of Arcoma was 2024 7.69 % . It decreases by 30.14% higher compared to the previous year.

The Arcoma FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
-0.73 SEK
Jan 1, 2019
-0.02 SEK
Jan 1, 2020
-4.13 SEK
Jan 1, 2021
-5.22 SEK
Jan 1, 2022
-3.48 SEK
Jan 1, 2023
10.19 SEK
Jan 1, 2024
7.69 SEK
Jan 1, 2025
10.01 SEK
The Arcoma FCF Margin history
YEARFCF MarginYoY
10.01 %+30.14%
7.69 %-24.48%
10.19 %-392.98%
-3.48 %-33.45%
-5.22 %+26.36%
-4.13 %+19,639.71%
-0.02 %-97.13%
-0.73 %-94.43%
-13.09 %+141.15%
-5.43 %-32.41%
-8.03 %+66.73%
-4.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

Free Cash Flow Margin of Arcoma is 10.01 % in 2025.

Free Cash Flow Margin of Arcoma changed from 7.69 % to 10.01 %, representing a 30.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Arcoma since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Arcoma with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Arcoma

All Key Metrics — Arcoma